Tirzepatide Online: Providers Compared by Monthly Price
Yes. You can get tirzepatide online: a telehealth visit for the prescription, then a mail-order pharmacy. Self-pay starts at $299 a month (LillyDirect: LillyDirect vial or KwikPen 2.5 mg). WeightWatchers Med+ charges $373 a month all in.
- Lowest self-pay
- $299 a month
- Telehealth from, all in
- $373 a month
- Prescription
- Required
- Shortage
- Resolved
Zepbound overview
Its half-life ranges from 5 to 6 days. After 5.5 days, half remains, while about 3% stays after five half-lives (27.5 days).
In SURMOUNT-1 over 72 weeks, people lost 20.9% of body weight, compared with 3.1% on placebo.
Monthly prices in US dollars include list prices and self-pay offers. Each comes from the maker's price page.
Sources: FDA label (DailyMed), Eli Lilly 1 2, cnbc.com.
Every legitimate way to get tirzepatide, ranked
| Route | Who it is for | What you pay |
|---|---|---|
| Mounjaro: Your doctor, with insurance and the savings card | Commercial insurance that covers it | A fill of up to 3 months may cost as little as $25 |
| Zepbound: The savings card and insurance, along with your doctor | Commercial insurance that covers it | A fill of up to 3 months may cost as little as $25 |
| Zepbound: LillyDirect: LillyDirect vial or KwikPen 2.5 mg | Anyone with a prescription, no insurance needed | $299 a month |
| Zepbound: TrumpRx listing (vial, starting) | Self-pay only | $299 a month |
| Zepbound: Walmart Pharmacy: LillyDirect self-pay (lowest dose) | Cash at the pharmacy counter | $299 a month |
| Telehealth: WeightWatchers Med+, Zepbound (self-pay) | Online visit, medicine shipped | $373 a month all in |
| Compounded copy: Mochi Health | Not FDA approved; ranked last for that reason | $90 a month |
Prices checked November 2026. Each price links to its source page.
Sources: pricinginfo.lilly.com, mounjaro.lilly.com, GoodRx, zepbound.lilly.com.
Who can qualify
Every GLP-1 requires a prescription in the US. A prescriber writes one for a use approved by the label:
- Mounjaro: It lowers blood sugar in adults and children ages 10 and up with type 2 diabetes.
- Mounjaro helps lower the risk of a heart attack, stroke, or heart-related death among adults with type 2 diabetes who are at high risk.
- Zepbound helps adults with obesity lose weight and keep it off over time when used with diet and activity. It also helps adults who are overweight and have a weight-related condition.
- Zepbound: It treats moderate to severe obstructive sleep apnea in adults with obesity.
Source: FDA label (DailyMed).
Telehealth options compared
| Program | Medicine option | Medicine price | Membership | All in |
|---|---|---|---|---|
 WeightWatchers Med+ | Zepbound (self-pay) | $299 a month | $74 a month | $373 a month |
 Ro | Zepbound KwikPen, starting dose | $299 a month | $149 a month | $448 a month |
 Hims & Hers | Zepbound | $1,899 a month | $149 a month after first month | $2,048 a month |
| Hims & Hers | Mounjaro | $1,899 a month | $149 a month after first month | $2,048 a month |
 Mochi Health | Compounded tirzepatide (not FDA approved) | $90 a month | $79 a month after free first month | $169 a month |
 Found | Compounded GLP-1 plan (not FDA approved) | $99 a month | $169 a month cash | $268 a month |
 Noom Med | (not FDA approved) Compounded GLP-1 plus GIP through the GLP-1Rx Plus Program | once the first 4 weeks are done, the cost is $299 a month, billed quarterly | Not listed | Included |
The pricing comes from each program's own pricing page. We do not earn money from any of these programs
Sources: weightwatchers.com, ro.co, hims.com, joinmochi.com.
Shortage status
Tirzepatide: The Shortage has been resolved. On December 19, 2024, the FDA confirmed it.
- The FDA shortage list first included it on December 15, 2022
- Shortage resolved: December 19, 2024
- Compounding copies: February 18, 2025 was when state pharmacies had to stop
- Outsourcing facilities had to stop on March 19, 2025
Source: FDA.
Scam signals
- No prescription needed: Any seller that skips the prescription is not a licensed US pharmacy.
- A brand price far below what the manufacturer charges: the brand's lowest self-pay cost is $299 a month
- Selling a compounded drug as the brand: These drugs lack FDA approval and cannot be Ozempic, Wegovy, Mounjaro or Zepbound.
- Calling a product the same as the brand: 30 warning letters about misleading claims were sent to telehealth companies.
- Harm reports: More than 730 adverse-event reports are connected to compounded tirzepatide.
- A monthly price that includes no drug: The FTC acted against one program over this; see the NextMed review.
Sources: pricinginfo.lilly.com, mounjaro.lilly.com, GoodRx, zepbound.lilly.com.
Find it in your state
- Hims & Hers: Offered in fewer than 50 states
- Noom Med: Not offered in all 50 states
- NovoCare Pharmacy: Its delivery network covers all 50 states, DC, Puerto Rico
The route changes most under Medicaid rules. for weight loss, 10 state Medicaid programs now cover GLP-1s. Select your state to view its drug list and prior authorization rules:
- Alabama
- Alaska
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- Florida
- Georgia
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming